Evidence supporting the use of: Corilagin
For the health condition: Hepatitis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Corilagin is a tannin compound found in various medicinal plants, such as Phyllanthus urinaria, which has been traditionally used in some Asian countries for liver disorders, including hepatitis. However, the use of Corilagin itself as a treatment for hepatitis is supported primarily by preclinical scientific studies, not by long-standing traditional use of the isolated compound.

Several in vitro and animal studies have demonstrated that Corilagin possesses hepatoprotective, anti-inflammatory, and antiviral properties. For example, Corilagin has been shown to inhibit hepatitis B virus (HBV) DNA replication in cell culture models and reduce markers of liver inflammation and damage in animal models of hepatitis. Mechanisms of action proposed include the suppression of pro-inflammatory cytokines, attenuation of oxidative stress, and interference with viral replication pathways.

Despite these promising preclinical results, there is a lack of robust clinical trials in humans to confirm the efficacy and safety of Corilagin for the treatment of hepatitis. Most of the current evidence is limited to laboratory and animal studies, with no high-quality human data published as of 2024. Therefore, while scientific research provides some support for the potential of Corilagin in managing hepatitis, the evidence is preliminary, and its clinical use cannot be recommended without further trials.

More about Corilagin
More about Hepatitis

Products containing Corilagin

We currently have no products on Vitabase that contain this ingredient.